van Geel, R. M., Tabernero, J., Elez, E., Bendell, J. C., Spreafico, A., Schuler, M., . . . Schellens, J. H. (2017). A Phase 1b Dose-Escalation Study of Encorafenib (LGX818) and Cetuximab With or Without Alpelisib in Metastatic BRAF-Mutant Colorectal Cancer. Cancer Discov.
Style de citation Chicagovan Geel, Robin M.J.M., et al. "A Phase 1b Dose-Escalation Study of Encorafenib (LGX818) and Cetuximab With or Without Alpelisib in Metastatic BRAF-Mutant Colorectal Cancer." Cancer Discov 2017.
Style de citation MLAvan Geel, Robin M.J.M., et al. "A Phase 1b Dose-Escalation Study of Encorafenib (LGX818) and Cetuximab With or Without Alpelisib in Metastatic BRAF-Mutant Colorectal Cancer." Cancer Discov 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.